Search Results 51-60 of 17014 for ulcerative%20colitis

  1. Study Of GS-1427 In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    The goal of this study is to learn if GS-1427 is effective in treating participants with moderate to severe ulcerative colitis. The study will compare ...

  2. The Relationship Between Endoscopic Inflammation and Health-related Quality of Life in Patients with Ulcerative Colitis - Mayo Clinic

    The Relationship Between Endoscopic Inflammation and Health-related Quality of Life in Patients with Ulcerative Colitis · More about research at Mayo Clinic.

  3. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

  4. Inflammatory Bowel Disease Clinic - Overview

    The Inflammatory Bowel Disease Clinic diagnoses and treats inflammatory bowel diseases, including ulcerative colitis, Crohn's disease and pouchitis.

  5. Crohn's disease - Symptoms and causes - Mayo Clinic

    Accessed May 21, 2024. Kellerman RD, et al. Inflammatory bowel disease: Crohn disease and ulcerative colitis. In: Conn's Current Therapy 2024. Elsevier; 2024.

  6. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis who have failed or be intolerant to one of following treatments for ulcerative colitis: oral steroids, azathiopurine/6-mercaptopurine, or ...

  7. Tofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic

    The Food and Drug Administration (FDA) recently expanded the approval of tofacitinib to include adults with moderately to severely active ulcerative colitis (UC) ...

  8. Comparing intestinal barrier function in patients with Crohn's disease or ulcerative colitis and healthy controls - Mayo Clinic

    The researchers observed impaired intestinal barrier function in patients with active Crohn's disease or ulcerative colitis that persists during remission.

  9. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    To evaluate safety and efficacy of two dosing regimens in achieving clinical remission at Week 8 in subjects with moderately to severely active Ulcerative ...

  10. Microscopic colitis - Symptoms and causes - Mayo Clinic

    Symptoms, testing and treatment are the same for both subtypes. Products & Services. A Book: Mayo Clinic on Crohn's Disease and Ulcerative Colitis · A Book ...